Healthcarenews19 Apr, 2024Business
The global cancer biomarkers market is experiencing significant growth and is projected to reach USD 28.2 billion by 2026, up from USD 12.4 billion in 2021, with a compound annual growth rate (CAGR) of 17.7%. This surge in growth can be attributed to several key factors, including the rising prevalence of cancer worldwide, increasing use of cancer biomarkers in drug discovery and development, and ongoing research and development efforts in the field of cancer biomarkers. Emerging markets such as India and Japan also offer lucrative opportunities for market players operating in this space.
Sezpro Nutrition
Techsolar
Gold Coast Respite
Maanavihomes
Alutech Panels
China Seo Xiaoyan. Mastering The Art
Roof Right Services
Nha Cai Uy Tin
Cwinbot
Aananda Herbals